SURVYR

TRLV

Trulieve Cannabis Corp.
$10.42
−$0.50 (4.58%)Oct 23 close
Healthcare CompareTechnicals
1M3M6M1Y2Y
-37%-8%+22%+51%+81%Oct 2025Oct 2026Apr 202652w high $13.2852w low $4.62
TRLVSPY
Wall St. Highest PT $21.00 (+101.5%) Wall St. Avg PT $18.18 (+74.5%)
$5$9$13$17$22POC $6Hi $21Avg $18
Underwater Drawdown %Max DD -54.4%Current -19.8%
0.0%-54.4%
Relative Strength vs SPY+26.7% vs SPYOutperforming
+75%0%-75%
1W
+$0.41 (4.10%)
1M
−$2.12 (16.91%)
3M
+$2.06 (24.64%)
6M
+$1.71 (19.63%)
YTD
+$1.73 (19.91%)
1Y
+$2.85 (37.65%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Strong Buy
7 analysts · mean score 1.14
1 = Strong Buy · 5 = Sell
Strong Buy114%
Buy686%
Hold00%
Underperform00%
Sell00%
Wall Street consensus
Analyst price targets
Current price$10.42
Average target$18.18
+$7.76 (+74.5%) upsideaverage target vs current price
CurrentAverageMedian
Low$15.00
Median$19.00
High$21.00
12-month Wall Street target range
Recent analyst rating changes · 3
Reiterated
2026-10-23 · Cantor Fitzgerald reiterated Overweight on TRLV
Reiterated
2026-08-07 · Cantor Fitzgerald reiterated Overweight on TRLV
Initiated
2026-07-20 · Cantor Fitzgerald started covering TRLV at Overweight
All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$2.0B
P/E (next 12 months, estimated)18.7
52-week range$4.62 – $13.28
Revenue growth (latest quarter vs a year ago)-10.3%
Dividend yieldNo dividend
Analyst consensusStrong Buy (7)
Average analyst price target$18.18 (+74%)

What they do

Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands.

Healthcare · Drug Manufacturers - Specialty & Generic
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

No sector grades for TRLV yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

TRLV earningsNext report in 8 days
Next report · quarter Sep 2026
Thu Nov 5, 2026Before the open
EPS consensus$0.07 range $0.02–$0.12
Revenue consensus$221.6M 3 analysts
Last 4 quarters · EPS vs estimate
Aug 7, 2026$0.11est $0.03+266.7%Above estimates
May 7, 2026$0.10est -$0.05+300.0%Above estimates
Feb 26, 2026-$0.02est -$0.03+31.0%Above estimates
Nov 5, 2025-$0.07est -$0.07−3.3%In line with estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · report time: Nasdaq earnings calendar · refreshed 2026-10-24 22:33:48 ET
24-1125-0225-0525-0825-1126-0226-0526-08-0.350.11
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$271.0M-10.3%
2026-03-31$286.8M–
2025-12-31$293.1M–
2025-09-30$288.2M–
2025-06-30$302.1M–

News & catalysts

More news
3 Great Biotech Stocks To Watch In October 2026
Simply Wall St. · Oct 16
Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve Cannabis
Zacks · Oct 12
3 Biotech Stocks To Watch In October 2026
Simply Wall St. · Oct 09
3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds
Zacks · Oct 09
Trulieve Repays $65 Million Mortgage Strengthening Balance Sheet
PR Newswire · Oct 07
Rating changes
Reiterated
2026-10-23 · Cantor Fitzgerald reiterated Overweight on TRLV
Reiterated
2026-08-07 · Cantor Fitzgerald reiterated Overweight on TRLV
Initiated
2026-07-20 · Cantor Fitzgerald started covering TRLV at Overweight

Third-party analyst actions, not SURVYR.'s views. All rating changes

Stats refreshed 2026-10-24 22:33:48 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026